LTRN - Lantern Pharma Inc.
3.98
0.120 3.015%
Share volume: 20,571
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$3.86
0.12
0.03%
Summary score
30%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.48%
Return on assets
-18.93%
Return on sales
0%
Return on invested capital
152.65%
Total debt ratio
20.58%
Debt ratio change over timeo
0%
Current Ratio
13.45%
Quick Ratio
0%
Cash Position Ratio
12.42%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-33.48%
Return on assets
-18.93%
Return on sales
0%
Return on invested capital
152.65%
Total debt ratio
20.58%
Debt ratio change over timeo
0%
Current Ratio
13.45%
Quick Ratio
0%
Cash Position Ratio
12.42%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.89%
Return on assets
-7.56%
Return on sales
0%
Return on invested capital
213.5%
Total debt ratio
4.1%
Debt ratio change over time
0%
Current Ratio
27.59%
Quick Ratio
0%
Cash Position Ratio
25.54%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LTRN | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -33.48% | 18.71% | 4.67% | 19.62% |
| Return on assets | -18.93% | 3.4% | 3.32% | 11.24% |
| Return on sales | 0% | 24.27% | 25.81% | 41.89% |
| Return on invested capital | 152.65% | 5.38% | 4.17% | -280.52% |
| Profitability | 25% | 47% | 29% | 75% |
| Total debt ratio | 20.58% | 78.91% | 58.54% | 54.01% |
| Debt ratio change over time | 0% | 0% | 10.69% | 0% |
| Dept financing | 7% | 25% | 44% | 17% |
| Current Ratio | 13.45% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 12.42% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 23% | 29% | 19% |
| Short-term ratios | LTRN | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -33.48% | 41.05% | 6.87% | 16.13% |
| Return on assets | -18.93% | 3.67% | 3.13% | 8.75% |
| Return on sales | 0% | 26.16% | 24.75% | 38.84% |
| Return on invested capital | 152.65% | 9.43% | 5.58% | -6.74% |
| Profitability | 25% | 54% | 30% | 60% |
| Total debt ratio | 20.58% | 91.28% | 61.3% | 55.02% |
| Debt ratio change over time | 0% | 0% | 13.89% | 0% |
| Dept financing | 6% | 25% | 42% | 15% |
| Current Ratio | 13.45% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 0% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 12.42% | 0.21% | 0.6% | 0.32% |
| Liquididy | 50% | 25% | 29% | 21% |
